Health Canada reviewing safety of drospirenone-containing oral contraceptives (Yasmin and Yaz) and risk of venous thromboembolism

Health Canada is currently reviewing two new studies recently published in the British Medical Journal that suggest the risk of blood clots with drospirenone-containing birth control pills may be two to three times greater than with birth control pills containing another type of progestin (levonorgestrel).

For more information,  click here.